BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
OMEGA LABORATORIES LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP in Canada?
Yes. BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG has an active shortage reported to Health Canada (last updated September 11, 2026).
Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP be available again?
The manufacturer's estimated resolution date is March 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BUPIVACAINE HYDROCHLORIDE INJECTION USP .75%
HOSPIRA HEALTHCARE ULC
MARCAINE 0.75% LIQ SPINAL 7.5MG/ML
SANOFI CANADA, INC.
MARCAINE 0.75% LIQ PRT 7.5MG/ML
SANOFI CANADA, INC.
SENSORCAINE
ASPEN PHARMACARE CANADA INC.
BUPIVACAINE HYDROCHLORIDE INJECTION USP .50%
HOSPIRA HEALTHCARE ULC
BUPIVACAINE HYDROCHLORIDE INJECTION USP .25%
HOSPIRA HEALTHCARE ULC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-03-31
~6 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02512424
Strength
7.5MG
Dosage Form
SOLUTION
Route
INTRASPINAL
Active Ingredient
BUPIVACAINE HYDROCHLORIDE
Tier
Tier 3 — Critical
Last Updated
2026-09-11
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from OMEGA LABORATORIES LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02150204
250MG · DIN 02486717
25MG · DIN 00582662
50MG · DIN 00582654
DIN 02251477
20% · DIN 00658413
0.5% · DIN 01936441
1MG · DIN 02238903
20MG · DIN 02526778
20MG · DIN 02526751
222MG · DIN 02056429
50G · DIN 00637955